Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage and disease control in patients with advanced ...
Duke Today

Saved by Duke Research

Federal funding has long played a crucial role in supporting research at Duke, a point underscored in a 1989 letter to the ...